Nurgül Yaşar

523 total citations
38 papers, 374 citations indexed

About

Nurgül Yaşar is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Nurgül Yaşar has authored 38 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Nurgül Yaşar's work include Lung Cancer Research Studies (7 papers), Lung Cancer Treatments and Mutations (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). Nurgül Yaşar is often cited by papers focused on Lung Cancer Research Studies (7 papers), Lung Cancer Treatments and Mutations (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). Nurgül Yaşar collaborates with scholars based in Türkiye, United States and Antigua and Barbuda. Nurgül Yaşar's co-authors include Abdullah Sakin, Çağlayan Geredeli, Aliye Soylu, Şener Cihan, Abdülbaki Kumbasar, Süleyman Şahin, Selvinaz Özkara, Kemal Dolay, Mustafa Kalaycı and Halil Alış and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Nurgül Yaşar

35 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nurgül Yaşar Türkiye 13 160 116 115 91 60 38 374
Libin Xu China 13 82 0.5× 106 0.9× 147 1.3× 89 1.0× 81 1.4× 41 507
Shinji Katsushima Japan 10 87 0.5× 131 1.1× 94 0.8× 107 1.2× 74 1.2× 21 454
Masahiro Shinoda Japan 12 162 1.0× 72 0.6× 167 1.5× 81 0.9× 53 0.9× 45 359
Aqsa Nasir United States 11 121 0.8× 136 1.2× 73 0.6× 56 0.6× 86 1.4× 24 352
Erika Hissong United States 11 121 0.8× 75 0.6× 99 0.9× 55 0.6× 73 1.2× 41 329
Jon D. Dorfman United States 9 168 1.1× 77 0.7× 64 0.6× 38 0.4× 180 3.0× 20 439
Masato Ueno Japan 15 97 0.6× 100 0.9× 147 1.3× 60 0.7× 157 2.6× 38 463
Takanobu Tabuchi Japan 11 282 1.8× 144 1.2× 205 1.8× 29 0.3× 56 0.9× 26 485
Richard Magdeburg Germany 11 135 0.8× 145 1.3× 194 1.7× 25 0.3× 115 1.9× 17 394

Countries citing papers authored by Nurgül Yaşar

Since Specialization
Citations

This map shows the geographic impact of Nurgül Yaşar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nurgül Yaşar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nurgül Yaşar more than expected).

Fields of papers citing papers by Nurgül Yaşar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nurgül Yaşar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nurgül Yaşar. The network helps show where Nurgül Yaşar may publish in the future.

Co-authorship network of co-authors of Nurgül Yaşar

This figure shows the co-authorship network connecting the top 25 collaborators of Nurgül Yaşar. A scholar is included among the top collaborators of Nurgül Yaşar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nurgül Yaşar. Nurgül Yaşar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Geredeli, Çağlayan, et al.. (2021). Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study. SHILAP Revista de lepidopterología. 17(2). 123–127. 6 indexed citations
3.
Şahin, Süleyman, et al.. (2020). The Effect of Body Mass Index on Treatment Outcomes in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Platinum-Based Therapy. Nutrition and Cancer. 73(8). 1411–1418. 4 indexed citations
4.
Sakin, Abdullah, et al.. (2019). Factors Affecting Disease-Free Survival in Operated Nonmetastatic Gastrointestinal Stromal Tumors. Journal of Surgical Research. 241. 170–177. 5 indexed citations
5.
Geredeli, Çağlayan, et al.. (2019). The effects of fulvestrant treatment on hormone receptor-positive metastatic breast cancer. The European Research Journal. 6(3). 210–215. 1 indexed citations
6.
Sakin, Abdullah, et al.. (2019). Prognostic Significance of Mean Platelet Volume on Local Advanced Non-Small Cell Lung Cancer Managed with Chemoradiotherapy. Scientific Reports. 9(1). 3959–3959. 17 indexed citations
7.
Sakin, Abdullah, et al.. (2019). The effect of body mass index on location of recurrence and survival in early-stage colorectal cancer. Journal of Cancer Research and Therapeutics. 16(8). 176–176. 8 indexed citations
8.
Sakin, Abdullah, et al.. (2019). Prognostic impact of blood transfusion in patients with metastatic non-small cell lung cancer receiving chemotherapy. Lung Cancer. 133. 38–44. 3 indexed citations
9.
Geredeli, Çağlayan & Nurgül Yaşar. (2018). FOLFIRI plus panitumumab in the treatment of wild-type KRAS and wild-type NRAS metastatic colorectal cancer. World Journal of Surgical Oncology. 16(1). 67–67. 2 indexed citations
10.
Sakin, Abdullah, et al.. (2018). Factors Affecting Survival in Neuroendocrine Tumors: A 15-Year Single Center Experience. Asian Pacific Journal of Cancer Prevention. 19(12). 3597–3603. 6 indexed citations
11.
Büyükaşık, Yahya, İbrahim C. Haznedaroğlu, Gülsüm Özet, et al.. (2017). The Modelled Effectiveness of Ruxolitinib on Survival in Polycythemia Patients with Hydroxyurea Resistance/Intolerance in Turkey. Value in Health. 20(9). A545–A545. 1 indexed citations
12.
Ünal, Olçun Ümit, İlhan Öztop, Serkan Menekşe, et al.. (2015). Adult Urological Soft Tissue Sarcomas: A Multicenter Study of the Anatolian Society of Medical Oncology (ASMO). Asian Pacific Journal of Cancer Prevention. 16(11). 4777–4780.
13.
Kefeli, Umut, Nurgül Yaşar, Özlem Erçelep, et al.. (2012). Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment. Biomarkers. 17(7). 663–667. 17 indexed citations
14.
Berk, Velı, Nuriye Özdemir, Metin Özkan, et al.. (2012). XELOX versus FOLFOX4 as Second Line Chemotherapy in Advanced Pancreatic Cancer. Hepatogastroenterology. 59(120). 2635–9. 15 indexed citations
15.
Korkmaz, Taner, S. Seber, Umut Kefeli, et al.. (2012). Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis. Clinical & Translational Oncology. 15(7). 535–540. 16 indexed citations
16.
Doğan, Yüksel, Aliye Soylu, Özgür Kılıçkesmez, et al.. (2010). The value of hepatic diffusion-weighted MR imaging in demonstrating hepatic congestion secondary to pulmonary hypertension. Cardiovascular Ultrasound. 8(1). 28–28. 10 indexed citations
17.
Kılıçkesmez, Özgür, et al.. (2009). Is quantitative diffusion-weighted MR imaging a reliable method in the assessment of the inflammatory activity in ulcerative colitis?. Diagnostic and Interventional Radiology. 16(4). 293–8. 19 indexed citations
18.
Soylu, Aliye, Özgür Kılıçkesmez, Şule Poturoğlu, et al.. (2009). Utility of diffusion-weighted magnetic resonance imaging for liver fibrosis in chronic active hepatitis. Diagnostic and Interventional Radiology. 16(3). 204–8. 19 indexed citations
19.
Soylu, Aliye, Ali Tüzün İnce, Nurgül Yaşar, et al.. (2009). Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin. Annals of Clinical Microbiology and Antimicrobials. 8(1). 12–12. 17 indexed citations
20.
Soylu, Aliye, Halil Alış, Kemal Dolay, et al.. (2008). Prevalence and Importance of Amebic Infestation in Patients with Ulcerative Colitis in Two Regions in Turkey. Digestive Diseases and Sciences. 54(6). 1292–1296. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Libin Xu Breakdown of academic impact, for papers by Shinji Katsushima Breakdown of academic impact, for papers by Masahiro Shinoda Breakdown of academic impact, for papers by Aqsa Nasir Breakdown of academic impact, for papers by Erika Hissong Breakdown of academic impact, for papers by Jon D. Dorfman Breakdown of academic impact, for papers by Masato Ueno Breakdown of academic impact, for papers by Takanobu Tabuchi Breakdown of academic impact, for papers by Richard Magdeburg
Rankless by CCL
2026